Gates Vascular Institute is First in WNY to Use New Miniature Cardiac Monitor

Updated: 3/24/2014

The Gates Vascular Institute recently announced that it is the first in Western New York to implant the smallest implantable cardiac monitoring device available, the Reveal LINQ Insertable Cardiac Monitor (ICM).

Medtronic’s Reveal LINQ ICM is approximately one-third the size of a AAA battery (~1 cc), making it more than 80 percent smaller than other implantable cardiac monitoring devices.

While significantly smaller, the device is part of a powerful system that allows physicians to continuously and wirelessly monitor a patient’s heart for up to three years, with 20 percent more data memory than its larger predecessor, Reveal® XT. 

"The Gates Vascular Institute is the premier center in Western New York for integration of all aspects of vascular care,” said Donald Switzer, MD, director of electrophysiology, Kaleida Health. “Immediately following the availability of this new technology, the cardiology and neurology teams at the Institute began modifying our existing protocols to incorporate the new injectable LINQ monitor. Now we're better able to predict which of our patients may be at risk for future strokes, even though they are unaware of any warning signs. By monitoring select patients 24 hours a day with wireless, continuous surveillance, we will instantly know of any abnormal heart rhythm events that can powerfully predict risk of future strokes, even if it occurs two years later."

In addition to its continuous and wireless monitoring capabilities, the system provides remote monitoring through the Carelink® Network. Through the Carelink Network, physicians can request notifications to alert them if their patients have had cardiac events.

The Reveal LINQ ICM is indicated for patients who experience symptoms such as dizziness, palpitation, syncope (fainting) and chest pain that may suggest a cardiac arrhythmia, and for patients at increased risk for cardiac arrhythmias.

Placed just beneath the skin through a small incision of less than one centimeter in the upper left side of the chest, the Reveal LINQ ICM is often nearly invisible to the naked eye once inserted. The device is placed using a minimally invasive insertion procedure, which simplifies the experience for both physicians and their patients. The Reveal LINQ ICM is MR-Conditional, allowing patients to undergo magnetic resonance imaging (MRI) if needed.

For 30-year-old Christine Fenzel, implantation of the Reveal LINQ ICM is the culmination of a years long search for answers to the cause of intermittent passing out, called syncope, which she has experienced since she was a child.

“It has been difficult to go through life never knowing if I am going to pass out or not,” said Fenzel. “I have been on medication for about 10 years, but they have gradually diminished in effectiveness. About three to four weeks ago, I passed out twice in one night, so I made an appointment with Dr. Switzer.”

“I am very happy with my implant,” she continued. “It is great to have the technology to do this. It is so small. Once I am healed, I will not even know it is there, and best of all, once we have the data, we can fine tune a treatment plan.”

The Reveal LINQ ICM is the latest addition to the revolutionary cardiac care provided at the Gates Vascular Institute.

Most recently, the Gates Vascular Institute became the first facility in Western New York to implant the world's first and only commercially available subcutaneous (below the skin) defibrillator for treatment of patients at risk of sudden cardiac arrest.

The Reveal LINQ system also includes the new MyCareLink ™ Patient Monitor, a simplified remote monitoring system with global cellular technology that transmits patients’ cardiac device diagnostic data to their clinicians from nearly any location in the world.

  

About Gates Vascular Institute  www.kaleidahealth.org/gvi
The Gates Vascular Institute, a Kaleida Health facility, is a combination of the finest researchers, surgeons, physicians, and other clinicians devoted to the study, treatment and prevention of cardiac, stroke, and vascular diseases.

About Buffalo General Medical Center  www.kaleidahealth.org/bgmc
Buffalo GeneralMedicalCenter, located next to the Gates Vascular Institute, is a not-for-profit, acute care teaching medical center. It is located in downtown Buffalo, NY, on the Buffalo Niagara Medical Campus, a growing epicenter of top clinical, research, and medical education institutions. As the proud flagship for Kaleida Health, Western New York’s largest healthcare system, Buffalo General Medical Center is a major referral center for the most complex cardiac, orthopedic, bariatric and general surgery services, just to name a few.

About Medtronic  www.medtronic.com
Medtronic, Inc., headquartered in Minneapolis, is the global leader in medical technology - alleviating pain, restoring health, and extending life for millions of people around the world.